Tuesday, November 25, 2025

Nutrien Sees Consensus Price Target Improvement Following Raised Guidance

On June 21st, Nutrien (TSX: NTR) raised their first half 2021 earnings per share guidance by $0.30 to $2.30 to $2.50 and announced that since the potash market has continued to tighten, they have upgraded capacity. They expect an additional half-million tonnes of potash of production output, after the June 7th half million tonne increase. These increases bring their expected potash sales volume to 13.3 – 13.8 million tonnes.

Off this news, a few analysts raised their 12-month price target on Nutrien, bringing their consensus 12-month price target to $66.71, up from $64.89, based on 20 analysts. Of those 20, three analysts have strong buy ratings, 13 have buy ratings, three have hold ratings and one analyst has a sell rating. The street high comes from Raymond James with an $82 price target and the lowest sits at $58 from Atlantic Equities.

BMO Capital Markets raised their 12-month price target to $70, from $65, and reiterated their outperform rating, calling this the dream scenario for Nutrien. The main reason for the raise is BMO marking-to-market their model for the recent fertilizer price surges and increased volume guidance by Nutrien. They believe that the average price now sits between $25-$70 per tonne but writes, “While we don’t see spot Brazil potash, NOLA urea, and Tampa DAP holding $500/t, $450/st or $660/t (all decade highs), we see prices still ending 2021E strong with Q4E averages of $425/t, $330/st and $520/t respectively.”

BMO believes that Nutrien can fill the gap for sanctions against Belarusian potash. They write, “We surmise NTR wants to make sure stakeholders understand NTR has much excess capacity in case the EU wants to really target Lukashenko.”

Below you can see BMO’s updated second quarter, 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

IAMGOLD Q3 Earnings: Market Responds With MASSIVE Price Lift

G Mining Q3 Earnings: Costs Down, Production Up

Endeavour Silver Q3 Earnings: On The Upswing

Recommended

Silver47 Hits 606 g/t Over 9.7 Metres Silver Equivalent In Final Assays From 2025 Drill Program At Red Mountain

Altamira Gold Encounters Second Porphyry Body, Hitting 3.5 g/t Gold Over 8.0 Metres

Related News

Dollarama: Canaccord Maintains $57 Price Target

On September 9, Dollarama Inc (TSX: DOL) reported their fiscal second quarter results for the...

Monday, September 13, 2021, 10:52:00 AM

Netflix: Q1 2021 Consensus Analyst Estimates

Netflix (NASDAQ: NFLX) will be reporting their first quarter financial results on April 20th after...

Monday, April 19, 2021, 04:10:00 PM

Ayr Wellness: Fourth Quarter Consensus Estimates

Ayr Wellness (CSE: AYR.a) is set to report their fourth quarter and year end financials...

Wednesday, March 10, 2021, 11:51:00 AM

Coeur Mining: BMO Lifts Target To $4 After Asset Sale

Coeur Mining (NYSE: CDE) on Monday announced that they have agreed to sell their Crown...

Wednesday, September 21, 2022, 03:46:00 PM

Antibe Therapeutics: Canaccord Initiates Coverage, Issues $1.50 Price Target

Recently, Canaccord Genuity’s Tania Gonsalves initiated coverage on Antibe Therapeutics (TSXV: ATE), a biotechnology company...

Tuesday, August 18, 2020, 01:46:28 PM